Aurobindo Pharma Market Cap

Aurobindo Pharma has a market cap or net worth of 629.36 billion as of August 14, 2025. Its market cap has decreased by -23.25% in one year.

Market Cap

629.36B

Enterprise Value

629.57B

Revenue

320.25B

Ranking

n/a

PE Ratio

18.58

Stock Price

1,082.10

Market Cap Chart

Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 629.36B, an increase of 6,453.56%. That is a compound annual growth rate of 19.81%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	629.36B	-18.80%
Dec 31, 2024	775.08B	22.03%
Dec 29, 2023	635.16B	147.32%
Dec 30, 2022	256.82B	-40.31%
Dec 31, 2021	430.28B	-20.29%
Dec 31, 2020	539.83B	101.66%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	3,892.20B
Divi's Laboratories	1,582.46B
Cipla	1,229.07B
Apollo Hospitals Enterprise	1,040.50B
Mankind Pharma	1,003.22B
Zydus Lifesciences	961.61B
Fortis Healthcare	703.36B
Alkem Laboratories	615.64B

Market Cap Rankings